ciclopirox has been researched along with deferiprone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cruz, AR; Gallin, JI; Huang, CY; Zarember, KA | 1 |
| Jiang, Z; You, Q; Zhang, X | 1 |
| Davidoff, AM; Rankovic, Z; Wang, Y; Wu, Q; Yang, J; Young, B | 1 |
| D'Alliessi Gandolfi, D; Hanauske-Abel, HM; Hoque, M; Mathews, MB; Palumbo, P; Park, MH; Pe'ery, T; Saxena, D | 1 |
| Cracchiolo, B; Hanauske-Abel, HM; Heller, DS; Hoque, M; Jain, MR; Li, H; Mathews, MB; Mémin, E; Pe'ery, T | 1 |
| Angulo, J; Cáceres, CJ; Contreras, N; López-Lastra, M; Pino, K; Vera-Otarola, J | 1 |
2 review(s) available for ciclopirox and deferiprone
| Article | Year |
|---|---|
Medicinal chemistry of metal chelating fragments in metalloenzyme active sites: A perspective.
Topics: Animals; Catalytic Domain; Chelating Agents; Chemistry, Pharmaceutical; Drug Design; Humans; Metalloproteins | 2019 |
Recent Advances with KDM4 Inhibitors and Potential Applications.
Topics: Enzyme Inhibitors; Histone Demethylases; Humans; Jumonji Domain-Containing Histone Demethylases; Neoplasms | 2022 |
4 other study(ies) available for ciclopirox and deferiprone
| Article | Year |
|---|---|
Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Ciclopirox; Deferiprone; Drug Combinations; Fluconazole; Iron Chelating Agents; Ketoconazole; Microbial Sensitivity Tests; Pyridones | 2009 |
Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.
Topics: Anti-HIV Agents; Ciclopirox; Deferiprone; Enzyme Inhibitors; Eukaryotic Translation Initiation Factor 5A; Gene Expression; HIV-1; Humans; Leukocytes, Mononuclear; Lysine; Mixed Function Oxygenases; Peptide Initiation Factors; Pyridones; RNA-Binding Proteins; Virus Replication | 2009 |
Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation.
Topics: Antifungal Agents; Cell Proliferation; Ciclopirox; Deferiprone; Eukaryotic Translation Initiation Factor 5A; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Silencing; HeLa Cells; Humans; Iron Chelating Agents; Mixed Function Oxygenases; NF-kappa B; Peptide Initiation Factors; Protein Processing, Post-Translational; Proteomics; Pyridones; RNA Interference; RNA-Binding Proteins; Uterine Cervical Neoplasms | 2014 |
Targeting deoxyhypusine hydroxylase activity impairs cap-independent translation initiation driven by the 5'untranslated region of the HIV-1, HTLV-1, and MMTV mRNAs.
Topics: 5' Untranslated Regions; Animals; Ciclopirox; Deferiprone; Eukaryotic Translation Initiation Factor 5A; Gene Expression; HEK293 Cells; HeLa Cells; HIV-1; Human T-lymphotropic virus 1; Humans; Mammary Tumor Virus, Mouse; Mice; Mixed Function Oxygenases; Peptide Initiation Factors; Protein Biosynthesis; Pyridones; RNA-Binding Proteins; RNA, Messenger | 2016 |